 |
|
|
|
|
|
|
|
|
|
| |
Institutional Biosafety Committees (IBCs) are the cornerstone of institutional oversight of recombinant DNA research. The following information and resources are provided to help IBCs perform this critical role, as well as to inform others about the roles and responsibilities of these important committees.
|
|
|
| |
 |
Key Definitions and Acronyms
|
|
|
| |
|
Frequently Asked Questions
|
|
|
| |
|
Guidance Documents
|
|
|
| |
 |
Institutional Compliance Reminder (December 6, 2004)
|
|
|
| |
|
Guidance on Minutes of Institutional Biosafety Committee Meetings (May 14, 2004)
|
|
|
| |
|
Additional Guidance on the Content of Minutes of Institutional Biosafety Committee Meetings (February 23, 2007)
|
|
|
| |
|
Major Actions Requiring NIH Director Approval (March 21, 2008)
|
|
|
| |
|
Workshops, Safety Symposia and Policy Conferences
|
|
|
| |
|
Links of Interest to IBCs
|
|
|
| |
|
Subscribe to OBA News
|
|
|
| |
If you have questions about OBA's activities, interpretations of the NIH Guidelines, upcoming meetings, or related matters, do not hesitate to contact OBA staff by email at oba@od.nih.gov, or by phone at 301-496-9838.
|
|
